JP2010518007A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010518007A5 JP2010518007A5 JP2009548329A JP2009548329A JP2010518007A5 JP 2010518007 A5 JP2010518007 A5 JP 2010518007A5 JP 2009548329 A JP2009548329 A JP 2009548329A JP 2009548329 A JP2009548329 A JP 2009548329A JP 2010518007 A5 JP2010518007 A5 JP 2010518007A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- polypeptide
- sema6a
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89899207P | 2007-02-02 | 2007-02-02 | |
| US60/898,992 | 2007-02-02 | ||
| PCT/US2008/001444 WO2008097503A2 (en) | 2007-02-02 | 2008-02-04 | Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010518007A JP2010518007A (ja) | 2010-05-27 |
| JP2010518007A5 true JP2010518007A5 (https=) | 2011-03-24 |
| JP5492567B2 JP5492567B2 (ja) | 2014-05-14 |
Family
ID=39682299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548329A Active JP5492567B2 (ja) | 2007-02-02 | 2008-02-04 | 髄鞘形成およびオリゴデンドロサイト分化を促進するためのセマフォリン６ａの使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9107884B2 (https=) |
| EP (1) | EP2114433B1 (https=) |
| JP (1) | JP5492567B2 (https=) |
| KR (1) | KR20090123873A (https=) |
| CN (1) | CN101631559A (https=) |
| AU (1) | AU2008214337B2 (https=) |
| BR (1) | BRPI0806849A2 (https=) |
| CA (1) | CA2677228C (https=) |
| EA (1) | EA017403B1 (https=) |
| GE (1) | GEP20135853B (https=) |
| IL (1) | IL200123A (https=) |
| MX (1) | MX2009008178A (https=) |
| NZ (1) | NZ578816A (https=) |
| SG (1) | SG178744A1 (https=) |
| UA (1) | UA99452C2 (https=) |
| WO (1) | WO2008097503A2 (https=) |
| ZA (1) | ZA200905379B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871205B2 (en) * | 2009-11-25 | 2014-10-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for the treatment of immune disorders |
| DK2820042T3 (da) * | 2012-02-29 | 2019-10-28 | Baxalta GmbH | Igg-stimuleret remyelinisering af perifere nerver |
| SG11201703148TA (en) | 2014-11-05 | 2017-05-30 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
| CN119876138A (zh) | 2014-11-14 | 2025-04-25 | 沃雅戈治疗公司 | 调节性多核苷酸 |
| CA3193811A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| KR20170138410A (ko) * | 2015-02-23 | 2017-12-15 | 시걸 테라퓨틱스 에스에이에스 | 비-천연 세마포린 3 및 이의 의학적 용도 |
| JP6924708B2 (ja) * | 2015-06-29 | 2021-08-25 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | Ｂ１ｓｐ融合タンパク質の治療薬、方法、および使用 |
| CA3024448C (en) | 2016-05-18 | 2025-09-09 | Voyager Therapeutics, Inc. | MODULATING POLYNUCLEOTIDES |
| JP7109040B2 (ja) * | 2016-07-25 | 2022-07-29 | 国立大学法人金沢大学 | 線維化抑制剤 |
| EP3618839A4 (en) | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| SG11202011296VA (en) | 2018-05-15 | 2020-12-30 | Voyager Therapeutics Inc | Compositions and methods for the treatment of parkinson's disease |
| CN109536506B (zh) * | 2018-12-10 | 2022-03-22 | 潍坊科技学院 | 一种调控日本沼虾生长发育的类胰岛素受体基因及其应用 |
| WO2025105734A1 (ko) * | 2023-11-15 | 2025-05-22 | 주식회사 카인사이언스 | 탈수초 질환 치료용 펩타이드 및 이의 용도 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773319A (en) | 1971-12-16 | 1973-11-20 | Fabcor Ind Inc | Corrugated sheet inverting machine |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| EP0154316B1 (en) | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| AU584417B2 (en) | 1985-04-01 | 1989-05-25 | Lonza Group Ag | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| ATE195022T1 (de) | 1987-04-27 | 2000-08-15 | Unilever Nv | Spezifische bindungstestverfahren |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5336603A (en) | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| ATE120454T1 (de) | 1988-06-14 | 1995-04-15 | Cetus Oncology Corp | Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus. |
| EP0401384B1 (en) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| IE63847B1 (en) | 1989-05-05 | 1995-06-14 | Res Dev Foundation | A novel antibody delivery system for biological response modifiers |
| US5314995A (en) | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
| AU654811B2 (en) | 1990-03-20 | 1994-11-24 | Trustees Of Columbia University In The City Of New York, The | Chimeric antibodies with receptor binding ligands in place of their constant region |
| US5219837A (en) | 1990-06-21 | 1993-06-15 | Trustees Of The University Of Pennsylvania | Method of stimulating myelination of cells |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| DE69133036T2 (de) | 1990-11-09 | 2003-02-06 | Stephen D. Gillies | Cytokine immunokonjugate |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| DE669986T1 (de) | 1992-11-13 | 1996-10-10 | Idec Pharma Corp | Völlig unfunktionelle konsensus-kozak-sequenzen zur säugetier-exprimierung. |
| US6068829A (en) | 1995-09-11 | 2000-05-30 | The Burnham Institute | Method of identifying molecules that home to a selected organ in vivo |
| ES2242997T3 (es) | 1997-03-14 | 2005-11-16 | Biogen Idec Inc. | Metodo para integrar genes en sitios especificos en celulas de mamifero por medio de recombinacion homologa y vectores para realizar el mismo. |
| EP1365018A1 (en) | 2002-05-23 | 2003-11-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | CD100 semaphorin in myelination |
| AU2003245387A1 (en) * | 2002-05-30 | 2003-12-19 | Curagen Corporation | Semaphorin-like proteins and methods of using same |
-
2008
- 2008-02-04 SG SG2012007456A patent/SG178744A1/en unknown
- 2008-02-04 BR BRPI0806849-6A patent/BRPI0806849A2/pt not_active Application Discontinuation
- 2008-02-04 CN CN200880003680A patent/CN101631559A/zh not_active Withdrawn
- 2008-02-04 MX MX2009008178A patent/MX2009008178A/es active IP Right Grant
- 2008-02-04 CA CA2677228A patent/CA2677228C/en active Active
- 2008-02-04 GE GEAP200811447A patent/GEP20135853B/en unknown
- 2008-02-04 KR KR1020097018262A patent/KR20090123873A/ko not_active Ceased
- 2008-02-04 EP EP08713389.8A patent/EP2114433B1/en active Active
- 2008-02-04 EA EA200901067A patent/EA017403B1/ru not_active IP Right Cessation
- 2008-02-04 NZ NZ578816A patent/NZ578816A/en not_active IP Right Cessation
- 2008-02-04 US US12/525,514 patent/US9107884B2/en active Active
- 2008-02-04 UA UAA200908176A patent/UA99452C2/ru unknown
- 2008-02-04 WO PCT/US2008/001444 patent/WO2008097503A2/en not_active Ceased
- 2008-02-04 JP JP2009548329A patent/JP5492567B2/ja active Active
- 2008-02-04 AU AU2008214337A patent/AU2008214337B2/en not_active Ceased
-
2009
- 2009-07-28 IL IL200123A patent/IL200123A/en active IP Right Grant
- 2009-07-31 ZA ZA2009/05379A patent/ZA200905379B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010518007A5 (https=) | ||
| JP2009544703A5 (https=) | ||
| US20240010708A1 (en) | Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods | |
| JP2011500566A5 (https=) | ||
| JP6942744B2 (ja) | 生物学的に活性な特異的カーゴペプチドと結合したヒト由来の細胞透過性ペプチドの構造、製造および使用 | |
| US6531295B1 (en) | Synthetic constructs encoding syndecan | |
| JP2011503069A5 (https=) | ||
| JP5492567B2 (ja) | 髄鞘形成およびオリゴデンドロサイト分化を促進するためのセマフォリン６ａの使用 | |
| JP2006507228A (ja) | 応答性の細胞、組織および器官を保護、回復ならびに増強するための組換え型組織保護サイトカインおよびそれをコードする核酸 | |
| Beerens et al. | Protein transduction domains and their utility in gene therapy | |
| JP2007511232A5 (https=) | ||
| US6800286B1 (en) | Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof | |
| EP2406281B1 (en) | Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity | |
| CN102805859A (zh) | 作为体内造血刺激剂的tat-hoxb4h重组蛋白质及其医疗组成物 | |
| NZ568705A (en) | Methods for promoting neurite outgrowth and survival of dopaminergic neurons | |
| JP2009518299A5 (https=) | ||
| CZ295997A3 (cs) | Způsob kultivace buněk | |
| CN1339068A (zh) | 转移核酸通过核被膜的细胞转运系统的用途 | |
| EP3263582B1 (en) | Polymer compound which has membrane-permeable peptide in side chain | |
| WO2007110079A2 (en) | Targeted delivery of fgfr ligands into the brain | |
| WO2024054062A1 (ko) | 세포 내 형질주입을 위한 신규한 폴리펩타이드 조성물 | |
| JP2004515534A (ja) | 生存を促進するｎｃａｍ結合化合物およびｎｃａｍリガンド結合化合物 | |
| US11472845B2 (en) | Antitumor peptide and use thereof | |
| KR20260011856A (ko) | Kkkk 돌연변이 adamts1 펩타이드 및 이를 포함하는 근육 질환 치료용 약제학적 조성물 | |
| WO2025225980A1 (ko) | Nm3 돌연변이 adamts1 펩타이드 및 이를 포함하는 근육 질환 치료용 약제학적 조성물 |